1Renaut L, Colin M, Leite JP, et al.Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.Virology, 2004,321:189-204.
2Mizuguchi H, Koizumi N, Hosono T, et al.CAR- or alphav integrinbinding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.Gene Ther, 2002 9:769-776.
3Koizumi N, Mizuguchi H, Sakurai F, et al.Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.J Virol, 2003,77:13062-13072.
4Contreras JL, Wu H, Smyth CA, et al.Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets.Transplantation,2003, 76:252-261.
5Koizumi N, Mizuguchi H, Sakurai F, et al.Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR-and alphav integrin-binding ablation.J Virol, 2003,77:13062-13072.
6Haisma HJ, Grill J, Curiel DT, et al.Targeting of edenoviral vectors through a bispecific single-chain antibody.Cancer Gene Ther, 2000,7:901-904.
7Ogawara K, Rots MG, Kok R J, et al.A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.Hum Gene Ther,2004, 15:433-443.
8Fukuda K, Abei M, Ugai H, et al.E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.Cancer Res,2003,63: 4434-4440.
9Cascallo M, Capella G, Mazo A, et al.Ras-dependent oncolysis with an adenovirus VAI mutant.Cancer Res,2003,63:5544-5550.
10Nettelbeck DM, Rivera AA, Balague C, et al.Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.Cancer Res, 2002, 62: 4663-4670.
